Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 147, pseudogene (RNU6-147P) is a **pseudogene** related to the U6 small nuclear RNA (snRNA) family. The canonical U6 snRNA is a highly conserved, non-coding RNA component of the spliceosome, essential for the removal of introns from pre-mRNA during mRNA splicing[1][3]. In contrast, **pseudogenes** such as RNU6-147P are DNA sequences similar to functional genes but generally lack biological activity: they are not believed to be transcribed into functional RNA, nor do they encode proteins or possess known biological effects[5]. Pseudogenes can arise via duplication or retrotransposition events, and U6 snRNA pseudogenes are distributed across genomes by such mechanisms[5]. They serve primarily as markers of genome evolution and retrotransposition activity rather than as functional molecules or therapeutic targets. **Key insights:** - There is no known function, biological activity, disease role, or drug interaction for RNU6-147P specifically; it is not considered a therapeutic target, nor is it referenced as a biomarker or subject to safety concerns[5]. - The entry is correct in terms of molecular nomenclature but is not an actionable or relevant therapeutic target and lacks relevant structured data for most requested fields. - U6 pseudogenes should not be confused with the functional U6 snRNA, which is essential for splicing[1][3][5]. This entry is best classified as a **non-coding RNA pseudogene**, not a drug target, with no established functional or clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 147, pseudogene (RNU6-147P).